Trial Information

Summary: A Double-Blind, Placebo-Controlled Study of Acamprosate Added to Escitalopram and Behavioral Treatment in Major Depressive Disorder (MDD) with Comorbid Alcohol Abuse/Dependence

Are you drinking too much?

Are you having trouble cutting back on your drinking, despite the fact that it is creating problems in your life?

Are you also feeling sad, blue, or down in the dumps?

Do you no longer enjoy the things you used to?

If you’ve answered yes to these questions, you could be eligible to participate in a no cost research study at Massachusetts General Hospital.


Massachusetts General Hospital is looking for participants aged 18-65 for a study looking at treatments for people with both alcohol abuse and depression. The study involves weekly visits, medications, behavioral treatments and monitoring of your depression and alcohol use.


For more information about this and other depression studies, please contact 1-877-55-BLUES

Contact:

Dana L Charles
Depression Clinical and Research Program
50 Staniford
Suit 401
Boston, MA 02113
Telephone: 617-724-9458
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: July 21, 2008 at 3:19:52 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA